These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 31187242)
1. The T cell activating properties and antitumour activity of Staphylococcal Enterotoxin-like Q. He Y; Sun Y; Ren Y; Qiao L; Guo R; Du J; Zhu X; Liu Y; Lin J Med Microbiol Immunol; 2019 Dec; 208(6):781-792. PubMed ID: 31187242 [TBL] [Abstract][Full Text] [Related]
2. Increased T-cell stimulating activity by mutated SEC2 correlates with its improved antitumour potency. Liu Y; Xu M; Su Z; Cai Y; Zhang G; Zhang H Lett Appl Microbiol; 2012 Nov; 55(5):362-9. PubMed ID: 22925007 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells. Rich S; Seelig M; Lee HM; Lin J J Immunol; 1995 Jul; 155(2):609-18. PubMed ID: 7608539 [TBL] [Abstract][Full Text] [Related]
4. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18. Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440 [TBL] [Abstract][Full Text] [Related]
5. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines. Tokura Y; Yagi J; O'Malley M; Lewis JM; Takigawa M; Edelson RL; Tigelaar RE J Invest Dermatol; 1994 Jan; 102(1):31-8. PubMed ID: 8288908 [TBL] [Abstract][Full Text] [Related]
6. Prevention of superantigen-induced tolerance in vivo by interleukin-2 treatment. Belfrage H; Dohlsten M; Hedlund G; Kalland T Cancer Immunol Immunother; 1997 Apr; 44(2):77-82. PubMed ID: 9177468 [TBL] [Abstract][Full Text] [Related]
7. Tofacitinib Treatment Suppresses CD4+ T-Cell Activation and Th1 Response, Contributing to Protection against Staphylococcal Toxic Shock. Jarneborn A; Hu Z; Deshmukh M; Kopparapu PK; Jin T Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000566 [TBL] [Abstract][Full Text] [Related]
8. Induction of responsiveness in superantigen-induced anergic T cells. Role of ligand density and costimulatory signals. Heeg K; Wagner H J Immunol; 1995 Jul; 155(1):83-92. PubMed ID: 7602125 [TBL] [Abstract][Full Text] [Related]
9. T-cell cytotoxicity assays for studying the functional interaction between the superantigen staphylococcal enterotoxin A and T-cell receptors. Rosendahl A; Kristensson K; Riesbeck K; Dohlsten M Methods Mol Biol; 2000; 145():241-57. PubMed ID: 10820726 [No Abstract] [Full Text] [Related]
10. Staphylococcal enterotoxin B modulates V beta 8+ TcR-associated T-cell memory against conventional antigen. Bell SJ; Buxser SE Cell Immunol; 1995 Jan; 160(1):58-64. PubMed ID: 7842486 [TBL] [Abstract][Full Text] [Related]
11. Superantigen staphylococcal enterotoxin C1 inhibits the growth of bladder cancer. Liu T; Li L; Yin L; Yu H; Jing H; Liu Y; Kong C; Xu M Biosci Biotechnol Biochem; 2017 Sep; 81(9):1741-1746. PubMed ID: 28715277 [TBL] [Abstract][Full Text] [Related]
12. T cells made deficient in interleukin-2 production by exposure to staphylococcal enterotoxin B in vivo are primed for interferon-gamma and interleukin-10 secretion. Florquin S; Amraoui Z; Goldman M Eur J Immunol; 1995 May; 25(5):1148-53. PubMed ID: 7774618 [TBL] [Abstract][Full Text] [Related]
13. Superantigen enhancement of specific immunity: antibody production and signaling pathways. Torres BA; Perrin GQ; Mujtaba MG; Subramaniam PS; Anderson AK; Johnson HM J Immunol; 2002 Sep; 169(6):2907-14. PubMed ID: 12218104 [TBL] [Abstract][Full Text] [Related]
14. The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens. Litton MJ; Dohlsten M; Rosendahl A; Ohlsson L; Søgaard M; Andersson J; Andersson U Br J Cancer; 1999 Sep; 81(2):359-66. PubMed ID: 10496366 [TBL] [Abstract][Full Text] [Related]
15. HgCl(2)-induced human lymphocyte activation in vitro: a superantigenic mechanism? Loftenius A; Ekstrand J; Möller E Int Arch Allergy Immunol; 1999 Sep; 120(1):63-70. PubMed ID: 10529590 [TBL] [Abstract][Full Text] [Related]
16. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304 [TBL] [Abstract][Full Text] [Related]
17. Superantigen toxic shock syndrome toxin-1 (TSST-1) enhances the replication of HIV-1 in peripheral blood mononuclear cells through selective activation of CD4+ T lymphocytes. Hashimoto K; Shigeta S; Baba M J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):393-9. PubMed ID: 7583434 [TBL] [Abstract][Full Text] [Related]
18. IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12 / IL-4 stimulation in vitro. Niedbala W; Wei X; Liew FY Eur J Immunol; 2002 Feb; 32(2):341-7. PubMed ID: 11807773 [TBL] [Abstract][Full Text] [Related]
19. Direct activation of murine T cells by staphylococcal enterotoxins. Taub DD; Rogers TJ Cell Immunol; 1992 Apr; 140(2):267-81. PubMed ID: 1544163 [TBL] [Abstract][Full Text] [Related]
20. Bacterial superantigens reactivate antigen-specific CD8+ memory T cells. Coppola MA; Blackman MA Int Immunol; 1997 Sep; 9(9):1393-403. PubMed ID: 9310843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]